Página 3 - Melhores Metástases hepáticas médicos - TOP-85 médicos

Mais de 28 anos de experiência cirúrgica – O Dr. Ben-haim é especialista em cancros do fígado e do pâncreas no Sourasky Medical Center.

• Realizar procedimentos complexos de Whipple para cancros gastrointestinais
• Focar-se exclusivamente em cirurgias oncológicas
• Ser reconhecido entre os principais especialistas em cancro do fígado de Israel

O Prof. Wolfgang Köstler é especialista em medicina personalizada para o cancro, com foco em doenças oncológicas mamárias e ginecológicas. O seu trabalho em terapias direcionadas ajuda a adaptar os tratamentos para melhores resultados.

• Mais de 20 anos de experiência em oncologia médica
• Ex-vice-diretor de Oncologia da Universidade de Medicina de Viena
• Especialista em desenvolvimento de biomarcadores e biologia tumoral
• Consultor sénior na Wiener Privatklinik
• Ativo em redes europeias de oncologia e ensaios clínicos

O Professor Associado Tahsin Ozatli é especialista em cancro da mama, do pulmão e gastrointestinal no Hospital Universitário Istinye Liv.

• Mais de uma década de experiência em oncologia
• Trabalhar na Clínica de Oncologia de Ancara e no Hospital Regional de Formação e Investigação de Erzurum
• Ser promovido a Professor Associado em 2016

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

O Professor Gul Alco combina mais de 25 anos de experiência em oncologia radioterápica com liderança académica nas principais universidades turcas.

• Especializado no tratamento de metástases hepáticas utilizando técnicas de radiação precisas
• Professor no Departamento de Oncologia Radioterápica da Universidade Medipol de Istambul
• Formado pela Universidade de Istambul – a principal faculdade de medicina da Turquia
• Equilibrar a prática clínica com o ensino de futuros radioncologistas

Especializado em cirurgia laparoscópica para metástases hepáticas – formado nos melhores programas da Universidade de Istambul.

• Mais de 30 anos de experiência em cirurgia geral e laparoscópica
• Formação avançada em cirurgia laparoscópica bariátrica e oncológica
• Membro da Associação Turca de Cirurgia

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Mais de 30 anos de especialização em viroterapia – A Dra. Jaunalksne traz abordagens imunológicas de ponta para metástases hepáticas na Pallas Clinic.

• Chefe do Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Graduada pelo Instituto Médico de Riga com internato em Medicina Interna
• Concentrar-se em tratamentos inovadores de imunoterapia

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Especializado em Oncologia Médica com formação na Universidade Akdeniz – o Dr. Alemdar concentra-se em metástases hepáticas no Medical Park Antalya.

• Formado em Medicina Interna antes de se especializar em oncologia
• Experiência em vários hospitais de renome, incluindo a Universidade Akdeniz
• Cargo atual no Complexo Hospitalar Medical Park Antalya
• Membro de associações profissionais de oncologia

O Prof. Associado Nail Paksoy é especializado no tratamento de metástases hepáticas no Hospital Medipol Bahçelievler, com vasta pesquisa em oncologia.

• Certificado pela ESMO em Oncologia Médica
• Participar em múltiplos ensaios clínicos internacionais para tratamentos de cancro
• Publicar inúmeros artigos sobre cancros metastáticos
• Formação especializada (Fellowship) no Instituto de Oncologia da Universidade de Istambul

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Especialista em cirurgias oncológicas complexas, incluindo metástases hepáticas, nos Hospitais Büyük Anadolu.

• Especialista em cirurgias pancreáticas e das vias biliares
• Capacitado em cirurgias oncológicas e mamárias
• Experiente em procedimentos de cancro gástrico e do cólon
• Realizar cirurgias de cancro da tiroide e de obesidade

O Professor Rifaat Safadi chefia a unidade de doenças hepáticas do Centro Médico Hadassah, especializando-se em tratamentos hepáticos avançados com reconhecimento internacional.

• Formado sob a orientação do Professor Scott Friedman na Sinai School of Medicine em Nova York
• Membro de associações internacionais para o estudo do fígado
• Premiado por pesquisas sobre modulação imunológica da fibrose hepática
• Autor de inúmeros artigos em hepatologia
• Chefe da unidade de doenças hepáticas no Centro Médico Hadassah

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.